Comparison of the Short-Term Risk of Bleeding and Arterial Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Newly Treated With Dabigatran or Rivaroxaban Versus Vitamin K Antagonists: A French Nationwide Propensity-Matched Cohort Study

BACKGROUND—: The safety and effectiveness of non–vitamin K antagonist (VKA) oral anticoagulants, dabigatran or rivaroxaban, were compared with VKA in anticoagulant-naive patients with nonvalvular atrial fibrillation during the early phase of anticoagulant therapy. METHODS AND RESULTS—: With the use...

Descripción completa

Detalles Bibliográficos
Autores principales: Maura, Géric, Blotière, Pierre-Olivier, Bouillon, Kim, Billionnet, Cécile, Ricordeau, Philippe, Alla, François, Zureik, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885525/
https://www.ncbi.nlm.nih.gov/pubmed/26199338
http://dx.doi.org/10.1161/CIRCULATIONAHA.115.015710

Ejemplares similares

Ejemplares similares